Mirna Clemente

Mirna Clemente

Auto-generated profile, based on publicly available information

Mirna Clemente


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
MCM. Clemente
M. Clemente
MIMiguel
Miguel
KFKarina Bettega Felipe
Karina Bettega Felipe
CGC. Gribner
C. Gribner
PMP.F. Moura
P.F. Moura
OMO.G. Miguel
O.G. Miguel

8 June 2020 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
MCMirna Clemente
Mirna Clemente
MMMarilis D Miguel
Marilis D Miguel
KFKarina Bettega Felipe
Karina Bettega Felipe
CGCaroline Gribner
Caroline Gribner
PMPaula F Moura
Paula F Moura
OMObdúlio G Miguel
Obdúlio G Miguel

28 January 2021 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
MCMirna Clemente
Mirna Clemente
MMMarilis D. Miguel
Marilis D. Miguel
KFKarina B. Felipe
Karina B. Felipe
CGCaroline Gribner
Caroline Gribner
PMPaula F. Moura
Paula F. Moura
OMObdúlio G. Miguel
Obdúlio G. Miguel

1 January 2022 in Brazilian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
CGCaroline Gribner
Caroline Gribner
PMPaula Francislaine Moura
Paula Francislaine Moura
ARAna Angélica Ruscheweyh Rigoni
Ana Angélica Ruscheweyh Rigoni
MCMirna Clemente
Mirna Clemente
YRYanna Dantas Rattmann
Yanna Dantas Rattmann
EGEliane Carneiro Gomes
Eliane Carneiro Gomes

1 January 2022 in Brazilian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
CACíntia Aparecida Anjos
Cíntia Aparecida Anjos
MCMirna Clemente
Mirna Clemente
JDJosiane de Fátima Gaspari Dias
Josiane de Fátima Gaspari Dias
LBLigia Moura Burci
Ligia Moura Burci
RLRômulo de Oliveira Leite
Rômulo de Oliveira Leite
MMMarilis Dallarmi Miguel
Marilis Dallarmi Miguel

1 January 2019 in Pharmacognosy Reviews
Verified
Journal Article
Closed access
PDF file
MCMirna Clemente
Mirna Clemente
MMMarilis Dallarmi Miguel
Marilis Dallarmi Miguel
KFKarina Bettega Felipe
Karina Bettega Felipe
GFGislene Mari Fujiwara
Gislene Mari Fujiwara
LFLuiz Claudio Fernandes
Luiz Claudio Fernandes
OMObdulio Gomes Miguel
Obdulio Gomes Miguel
Nasturtium officinale (Watercress) is a perennial dicotyledonous herbaceous plant and a member of the Brassicaceae family. The leaves of this plant are used as a home remedy as expectorant and hypoglycemic. They can also be used in the treatment of hyperlipidemia, hypertension, as well as many other chronic diseases. This finding supports the idea of watercress being a health promoter. In addition, this study intends to provide recommendations for future research. This systematic review was performed by Science Direct, MEDLINE, Cochrane, and Scopus from July 2017 to August 2018. A total of 14 preclinical studies with watercress were selected by the inclusion and exclusion criteria, 13 were with rats and mice and 1 fish. The search terms used were “bioactive compounds,” “Nasturtium,” “preclinical study,” and “systematic review.” For the quality of the individual studies, we adopted the risk of bias. The results of the selected articles with Nasturtium in animals showed positive effects on the improvement of the immune system, hypoglycemic hypercholesterolemia, and anti-inflammatory activity, sex hormones synthesis, the preventive effect on the renal stone formation, and others. Since Nasturtium is widely used for therapeutic and nontherapeutic purposes that trigger its significant value, a new approach is necessary. Different combinations and the numerous medicinal properties of its extract juice and leaves, whether administrated orally or topically, demand further studies about other useful and unknown properties of this multipurpose plant. Finally, it is suggested by our reviewers that more studies with animals to be applied to human health, should be investigated of bioactive compounds from watercress.